Mefloquine Hydrochloride

CHEMBL535650 Phase 4 Onaylandı Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
414.8 g/mol
LogP
Phase
4

A hydrochloride salt form of mefloquine, an antimalarial agent used for prevention and treatment of chloroquine-resistant malaria, taken weekly for prophylaxis or as a treatment course.

Moleküler Ağırlık

414,8000 g/mol

TPSA

45,20 Ų

Terapötik Alanlar

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

Cl.OC(c1cc(C(F)(F)F)nc2c(C(F)(F)F)cccc12)C1CCCCN1

InChI

InChI=1S/C17H16F6N2O.ClH/c18-16(19,20)11-5-3-4-9-10(15(26)12-6-1-2-7-24-12)8-13(17(21,22)23)25-14(9)11;/h3-5,8,12,15,24,26H,1-2,6-7H2;1H

Molecular Formula

C17H17ClF6N2O

HBD / HBA

3 / 9

Döndürülebilir Bağlar

2

Ağır Atomlar

27

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

A hydrochloride salt form of mefloquine, an antimalarial agent used for prevention and treatment of chloroquine-resistant malaria, taken weekly for prophylaxis or as a treatment course.

Yes, Mefloquine Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL535650. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 65329. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.